35.50
+0.71%
Close of 9 Nov 2026, in THB
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Mega Lifesciences PCL
Its shares trade on SET under the ticker MEGA.BK. It has been listed since 19 November 2013. In the fiscal year to 31 December 2025, it reported revenue of THB 14.15bn and net income of THB 1.91bn. At that date it held total assets of THB 16.00bn and shareholders' equity of THB 10.22bn.
Mega Lifesciences Public Co. Ltd. engages in the manufacture, market, sale, and distribution of pharmaceutical, nutraceutical products, and consumer goods. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2013-11-19. The firm's products include complimentary medicines, over-the-counter (OTC) medicines and prescription medicines to both domestic and international markets. The company distributes products under Maxxcare brand covering prescription pharmaceutical products, OTC drugs and other consumer products. The firm also offers nutritional products, prescription pharmaceutical products and OTC drugs under Mega We Care brand. In addition, the Company operates as an original equipment manufacturer (OEM) for various products including health supplements, pharmaceutical, herbal products, vitamins and minerals, among others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 19 Nov 2013
- Employees
- 4,923
- Website
- megawecare.com ↗
Leadership
Pay as last reported
- Mr. Mechai ViravaidyaIndependent Chairman of the BoardTHB 2.3m
- Mr. Vivek DhawanChief Executive Officer, Executive Director, Chief Coach, since 2013
- Mr. Yim Kam ChiIndependent Vice Chairman of the BoardTHB 1.7m
- Mr. Thomas AbrahamChief Financial Officer, Executive Director, Head Coach, since 2013
- Mr. Paramjit SawhneyPresident - International, Head Coach
- Ms. Duangnapha TongsiriPresident - Thailand Mega We Care, Head Coach
- Mr. Girish WadhwaPresident - Myanmar, Head Coach
- Mr. Manoj GurbuxaniDeputy Chief Financial Officer
- Ms. Sujintana BoonworapatCompany Secretary
- Mr. Shiraz Erach PoonevalaNon-Executive DirectorTHB 694,575
- Mr. Ishaan ShahNon-Executive DirectorTHB 694,575
- Mr. Kirit ShahNon-Executive DirectorTHB 694,575
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 62
- Environment
- 66
- Social
- 99
- Governance
- 22
- Direct emissions (scope 1)
- 1,808.57 t
- Energy emissions (scope 2)
- 6,752.89 t
- Value chain emissions (scope 3)
- 439.53 t
- Women in the workforce
- 56.4%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Mega Lifesciences PCL has several strengths that contribute to its success:
Weaknesses
- Mega Lifesciences PCL faces certain weaknesses that pose challenges:
Opportunities
- Mega Lifesciences PCL can leverage the following opportunities for growth:
Threats
- Mega Lifesciences PCL should be aware of the following threats to its business:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.